vs

Side-by-side financial comparison of FLYEXCLUSIVE INC. (FLYX) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

FLYEXCLUSIVE INC. is the larger business by last-quarter revenue ($92.1M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). FLYEXCLUSIVE INC. runs the higher net margin — -4.6% vs -38.1%, a 33.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 19.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 21.9%).

FLYEXCLUSIVE INC. is a U.S.-headquartered private aviation services provider that offers private jet charter, aircraft management, maintenance repair, and fractional ownership programs. It primarily serves high-net-worth individuals, corporate clients, and government entities across North America, delivering personalized on-demand air travel solutions prioritizing safety and convenience.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

FLYX vs PRCT — Head-to-Head

Bigger by revenue
FLYX
FLYX
1.1× larger
FLYX
$92.1M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+0.4% gap
PRCT
20.2%
19.8%
FLYX
Higher net margin
FLYX
FLYX
33.4% more per $
FLYX
-4.6%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
21.9%
FLYX

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
FLYX
FLYX
PRCT
PRCT
Revenue
$92.1M
$83.1M
Net Profit
$-4.3M
$-31.6M
Gross Margin
13.7%
64.9%
Operating Margin
-12.3%
-4.1%
Net Margin
-4.6%
-38.1%
Revenue YoY
19.8%
20.2%
Net Profit YoY
32.0%
-27.9%
EPS (diluted)
$-0.25
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLYX
FLYX
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$92.1M
$83.3M
Q2 25
$91.3M
$79.2M
Q1 25
$88.1M
$69.2M
Q4 24
$68.2M
Q3 24
$76.9M
$58.4M
Q2 24
$79.0M
$53.4M
Net Profit
FLYX
FLYX
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-4.3M
$-21.4M
Q2 25
$-4.8M
$-19.6M
Q1 25
$-5.4M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-6.3M
$-21.0M
Q2 24
$-5.2M
$-25.6M
Gross Margin
FLYX
FLYX
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
13.7%
64.8%
Q2 25
15.0%
65.4%
Q1 25
12.8%
63.9%
Q4 24
64.0%
Q3 24
11.3%
63.2%
Q2 24
7.9%
59.0%
Operating Margin
FLYX
FLYX
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-12.3%
-27.8%
Q2 25
-13.5%
-28.0%
Q1 25
-16.7%
-39.7%
Q4 24
-28.9%
Q3 24
-27.2%
-38.4%
Q2 24
-27.6%
-50.3%
Net Margin
FLYX
FLYX
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-4.6%
-25.7%
Q2 25
-5.2%
-24.7%
Q1 25
-6.2%
-35.8%
Q4 24
-27.6%
Q3 24
-8.2%
-35.9%
Q2 24
-6.5%
-48.0%
EPS (diluted)
FLYX
FLYX
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.25
$-0.38
Q2 25
$-0.26
$-0.35
Q1 25
$-0.30
$-0.45
Q4 24
$-0.34
Q3 24
$-0.32
$-0.40
Q2 24
$-0.32
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLYX
FLYX
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$18.7M
$245.6M
Total DebtLower is stronger
$123.9M
$51.7M
Stockholders' EquityBook value
$-434.2M
$347.7M
Total Assets
$448.1M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLYX
FLYX
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$18.7M
$294.3M
Q2 25
$15.8M
$302.7M
Q1 25
$14.7M
$316.2M
Q4 24
$333.7M
Q3 24
$18.7M
$196.8M
Q2 24
$9.3M
$214.1M
Total Debt
FLYX
FLYX
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$123.9M
$51.6M
Q2 25
$111.6M
$51.5M
Q1 25
$121.6M
$51.5M
Q4 24
$51.5M
Q3 24
$197.9M
$51.4M
Q2 24
$206.3M
$51.4M
Stockholders' Equity
FLYX
FLYX
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$-434.2M
$380.3M
Q2 25
$-261.4M
$385.8M
Q1 25
$-281.5M
$389.2M
Q4 24
$402.2M
Q3 24
$-192.0M
$241.2M
Q2 24
$-149.7M
$251.8M
Total Assets
FLYX
FLYX
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$448.1M
$511.5M
Q2 25
$443.4M
$513.1M
Q1 25
$466.8M
$519.4M
Q4 24
$534.0M
Q3 24
$487.1M
$374.1M
Q2 24
$494.7M
$374.4M
Debt / Equity
FLYX
FLYX
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLYX
FLYX
PRCT
PRCT
Operating Cash FlowLast quarter
$-209.0K
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-12.0%
Capex IntensityCapex / Revenue
11.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-51.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLYX
FLYX
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$-209.0K
$-6.6M
Q2 25
$363.0K
$-15.0M
Q1 25
$-10.5M
$-17.0M
Q4 24
$-32.4M
Q3 24
$-12.3M
$-18.8M
Q2 24
$-16.2M
$-15.7M
Free Cash Flow
FLYX
FLYX
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-11.0M
$-9.5M
Q2 25
$353.0K
$-17.8M
Q1 25
$-14.6M
$-18.8M
Q4 24
$-33.6M
Q3 24
$-25.7M
$-19.0M
Q2 24
$-26.6M
$-16.8M
FCF Margin
FLYX
FLYX
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-12.0%
-11.4%
Q2 25
0.4%
-22.5%
Q1 25
-16.5%
-27.2%
Q4 24
-49.2%
Q3 24
-33.5%
-32.6%
Q2 24
-33.7%
-31.4%
Capex Intensity
FLYX
FLYX
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
11.7%
3.4%
Q2 25
0.0%
3.5%
Q1 25
4.7%
2.7%
Q4 24
1.7%
Q3 24
17.5%
0.4%
Q2 24
13.2%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLYX
FLYX

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons